Objective: To evaluate predischarge transcutaneous bilirubin (TcB) measurements combined with risk factors as predictors of the risk of a subsequent total serum bilirubin (TSB) X17 mg per 100 ml (291 mmol l
Introduction
In its clinical practice guideline on the management of hyperbilirubinemia in the newborn 1 the American Academy of Pediatrics (AAP) recommends that, before discharge, all infants be assessed, for the risk of subsequent severe hyperbilirubinemia. The AAP guideline notes that 'the best documented method for assessing the risk of subsequent hyperbilirubinemia is to measure the total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) level and plot the results on a nomogram.' First described by Bhutani et al. 2 in 1999, the measurement of a predischarge TSB level has been shown, in different populations, to be a valuable method for helping to assess the risk of an infant subsequently developing, or not developing, hyperbilirubinemia. [3] [4] [5] [6] Two recent studies 7, 8 have shown that combining a predischarge TSB or TcB measurement with clinical risk factors improved the prediction of subsequent hyperbilirubinemia. We evaluated different models for the prediction of hyperbilirubinemia to identify a simple and clinically relevant method of assessing the risk of subsequent hyperbilirubinemia in this population.
Methods
Since February 2005, nurses have routinely performed TcB measurements during the midnight shift (between 2300 and 0700 hours) on all infants in our well baby nursery. All measurements are obtained from the mid sternum as described earlier 9 using the Konica Minolta Dräger Air-Shields Transcutaneous Jaundice Meter, 9 and a TSB was ordered whenever the TcB exceeded the 95th percentile. Pediatricians could also order TSB levels at their discretion. Most infants had at least two TcB measurements before discharge.
Using the hospital's laboratory database, we performed a nested case-control study 10 and identified all infants (n ¼ 75) who, following discharge, had been readmitted with hyperbilirubinemia (a TSBX17 mg per 100 ml (291 mmol l À1 )) (cases). Infants who received phototherapy before discharge were omitted. From the remaining population of infants who were not readmitted for hyperbilirubinemia, we randomly selected 75 controls. We reviewed the charts and obtained demographic data on all infants and evaluated each variable and combination of variables to predict cases. For our risk calculations, all predischarge TcB measurements were plotted, retrospectively, on the Beaumont nomogram ( Figure 1) 9 developed from our population. As a predictor variable, the maximum predischarge TcB measurements were divided into four groups according to the percentiles (<50, 50 to 75, 76 to 95, >95). The TcB values used to predict hyperbilirubinemia in this study were derived from a different data set from those used to construct our nomogram. For our outcome variable we used a TSB of X17 mg per 100 ml (291 mmol l À1 ) (cases), which is approximately the 95th percentile on the Bhutani nomogram for infants aged X96 h. 2 All these infants received phototherapy but none required an exchange transfusion. The study was approved by the hospital's Human Investigation Committee.
Statistical analysis
We summarized continuous variables using mean±s.d., whereas categorical variables were summarized using frequencies and percentages. We compared cases with controls using the two-tailed Fisher's Exact test for nominal variables, the Exact Cochran-Armitage Trend test for ordinal variables, and the two-tailed Student's t-test for continuous variables. Stepwise multiple logistic regression analysis was used to determine the smallest subset of predictors that best explained the differences between cases and controls. For the model building process, we included all of the variables listed in Table 1 . Significance levels for entry and exit from the models were set at 0.05. As the various fitted models were correlated, the areas under the receiver operating characteristic (ROC) curve, as denoted by the c-statistics, were compared statistically using the methodology described for binary responses by DeLong et al.
11 P-values of <0.05 were considered statistically significant. Statistical analysis was performed using The SAS System for Windows, SAS Institute Inc., Cary, NC, USA (version 9.1.3, Service Pak 2).
Results

Between 1 February 2005 and 28
February 2007, 11 456 infants were discharged from the well baby nursery and 75 (0.65%) were readmitted at a mean age of 110±29.9 h with a TSBX17 mg per 100 ml, range 17.0 to 23.8 mg per 100 ml (291 to 407 mmol l À1 ). Demographic and clinical data are provided in Table 1 and the results are shown in Tables 2 and 3 and Figure 2 . Using logistic regression analysis, three variables were statistically significant for predicting cases: the predischarge TcB percentile group (P<0.0001), feeding method (exclusive breast, breast and formula vs formula only (reference group), P ¼ 0.0001), and gestational age group (P ¼ 0.0057). The odds ratios are provided in the tables. When assessing only the clinical predictors collectively (that is, excluding predischarge TcB percentile group), only the gestational age group and the feeding method were used (P ¼ 0.1982, 0.0012 and 0.0001, respectively). Sixty-two (83%) of the cases and 65 (87%) of the controls had two TcB measurements obtained before discharge. The calculated hourly rate of rise between the two measurements was 0.22 ± 0.07 mg per 100 ml (3.8 ± 1.2 mmol l À1 ) in the cases and 0.13 ± 0.07 mg per 100 ml (2.2 ± 1.2 mmol l À1 ) in the controls (P<0.0001). We also evaluated whether the rate of rise of the TcB values or the last TcB value measured before discharge might be better predictors of a case than the maximum TcB. As not every infant had two TcB levels measured, it was not possible to include Abbreviations: CI, conflict of interest; TcB, transcutaneous bilirubin; TSB, total serum bilirubin. a Relative risk calculated assuming a value of 1 for post-discharge TSB of X20 mg per 100 ml with predischarge TcB below 50th percentile. The denominators were calculated for each category using our TcB percentiles (Figure 1 ). To calculate the denominators it was assumed for each category that the non-readmitted infants did not develop a TSB X17 mg per 100 ml. the entire sample in the calculation of the rate of rise. We therefore assumed a cord TcB level of 1.7 mg per 100 ml based on published values of mean bilirubin levels in the cord blood. [12] [13] [14] When this was done, gestational age groups, feeding method, the calculated rate of rise and birth weight all entered the model and provided a c-statistic for the ROC curve of 0.903 (not significantly different from our original model P ¼ 0.316). When the last measured TcB was substituted for the peak TcB, the same variables entered the model (gestational age, feeding and percentile groups) with a c-statistic for the ROC curve of 0.873, not significantly different from either of the earlier calculated ROC curves (P ¼ 0.292).
Discussion
Several studies have shown good correlations between TcB and TSB measurements using instruments currently available in the United States [15] [16] [17] [18] and predischarge TcB measurements are recommended by the AAP as one method for assessing the risk of subsequently developing, or not developing hyperbilirubinemia. 1 Keren et al., 8 in a prospective cohort study, found that combining the predischarge TcB measurement with the gestational age (compared with the TcB measurement alone) improved the accuracy of the prediction of a subsequent TSB rising to within 1 mg per 100 ml of the hour-specific phototherapy treatment threshold recommended by the AAP. 1 Nevertheless, in that study, a combination of clinical risk factors was as predictive as combining the TcB with gestation and percentage of weight loss 8 . The demographic data for our cases are typical of a hyperbilirubinemic population, with a preponderance of infants at p38 weeks gestation and who were breastfed.
Our study has some strengths and limitations. Its strength is that it includes an entire population of newborn infants and their predischarge TcB measurements, obtained over a 32-month period. The limitations include the possibility of bias introduced by variations in management and follow-up. There was no standardized approach to the management of this cohort. Some 85% of our infants are followed by 236 private pediatricians and the balance by residents and pediatricians in the hospital follow-up clinic. It is likely that the predischarge TcB measurements influenced the subsequent surveillance and management of some infants. As the identification of post-discharge hyperbilirubinemia depended on the clinical judgment of the physician providing follow-up, some infants who had a TSB X17 mg per 100 ml (291 mmol l À1 ) might not have had a TSB measurement and could have been missed. If the predischarge TcB level was low, some infants might not have been followed closely and subsequent hyperbilirubinemia could have been missed. Although this is possible, it is unlikely, because compliance among our attending pediatricians for follow-up according to the AAP Guidelines is very high and is monitored continuously as part of our quality improvement program. During the period of this study our quality improvement monitor showed that 94% of infants discharged before 72 h were scheduled to be seen within 2 days of discharge and 98% within 3 days (unpublished data) so that it is unlikely, but not impossible, that an infant with a TSB X17 mg per 100 ml would not have had a measurement of TSB.
We chose the peak predischarge TcB as one of our main predictors because that is what has been used in earlier studies. 8, 15 Nevertheless, it could be argued that the TcB measurement obtained just before discharge or, the rate of rise of the TcB might be more predictive than the maximum TcB. We evaluated both of these possibilities and found that they did not improve the prediction of significant hyperbilirubinemia. To be user friendly, the prediction model should be as parsimonious as possible. In addition, with current the length of stays, the vast majority of the last measured TcBs is likely to represent the maximum TcB ( Figure 1 ). Even if this is not the case, the differences will be small and, as we found, unlikely to affect the results. Using the rate of rise requires an additional calculation and brought another variable (birth weight) into the model. In contrast, if two or more TcB measurements are obtained, a visual estimate showing that the rate of rise is crossing percentiles (Figure 1 ) suggests an increase in bilirubin production and the importance of closer monitoring.
The number of infants readmitted (0.65% of infants discharged) is consistent with other recent studies 19 as well as our data published earlier. 20 In our earlier study of 29 934 infants born between 1994 and 1998, only 0.4% were readmitted for phototherapy. 20 Finally, some of our pediatricians use home phototherapy. Although this would not have prevented us from identifying infants with TSB levels X17 mg per 100 ml (291 mmol l À1 ) from the laboratory database, home phototherapy is usually instituted at lower TSB levels (than in hospitalized infants), and is likely to prevent the TSB in some infants from reaching 17 mg per 100 ml. Thus, the total number of infants readmitted with TSB levels X17 mg per 100 ml (291 mmol l À1 ) is a minimum estimate.
There are benefits and potential hazards associated with the routine measurement of TSB or TcB, before discharge, in all newborns. As we and others have shown, a predischarge TcB or TSB can help predict the possibility of subsequent hyperbilirubinemia [2] [3] [4] [5] [6] 21 and, when combined with clinical risk factors, the accuracy of prediction is significantly improved. 7, 8 The other important benefit is that the TSB or TcB, when compared with the hour-specific nomogram, provides a quantifiable and real-time measure of the degree of hyperbilirubinemia in the infant and, in addition to its predictive value, alerts the caregiver to consider the implications, together with the clinical risk factors, of this bilirubin level: Should the TSB be repeated; is discharge appropriate; when should the follow-up take place; is the infant a candidate for phototherapy? These are some of the questions that need to be posed for every infant, before discharge, whether or not a TcB or TSB is done. In addition, there is some evidence that universal predischarge screening can reduce the number of infants who subsequently develop a TSB of >20 mg per 100 ml. 22, 23 Whether or not this will have any effect on the incidence of bilirubin encephalopathy remains to be seen.
The risks of such a program, however, should not be ignored. It is possible that predischarge screening will lead to additional and unnecessary testing and inappropriate use of phototherapy, and there is some evidence that this has occurred. 23 More testing and treatment could have a negative effect on breastfeeding. Finally, a low predischarge TSB or TcB can produce a false sense of security leading to inadequate follow-up or failure to obtain a TSB in a jaundiced infant at follow-up. Infants who have a low predischarge TSB or TcB can, nevertheless, develop hyperbilirubinemia and require phototherapy. In our study, five infants had a predischarge TcB below the 50th percentile but nevertheless developed a TSB >17 mg per 100 ml although none exceeded 20 mg per 100 ml.
Similar to the findings of Keren et al., 8 and Newman et al. 7 we found that simply combining the predischarge TcB measurement with the infants' gestational age provided a good prediction of the risk of the subsequent development of hyperbilirubinemia. When exclusive breastfeeding was also included, the prediction was slightly, although not significantly, better.
As more than 80% of infants had at least two TcB measurements in the hospital, the calculated rate of rise (or visual inspection of the values plotted on a nomogram) can help to identify infants in whom the TcB is rising more rapidly than expected. The rate of increase of TcB in the cases (0.22 mg per 100 ml per h) is identical to the rate in the first 24 h in our population at the 95th percentile 9 ( Figure 1 ) and is similar to the high-risk track in the Bhutani nomogram. 2 Thus, infants whose TcB is increasing at >0.2 mg per 100 ml per h deserve close observation.
We conclude that routine predischarge TcB measurements, obtained by the nursing staff in a busy nursery, when combined with the infant's gestation and the method of feeding, provide a simple and relevant measure of the risk for the subsequent development of hyperbilirubinemia.
